Page last updated: 2024-09-04

moxifloxacin and Chronic Bronchitis

moxifloxacin has been researched along with Chronic Bronchitis in 24 studies

Research

Studies (24)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	20 (83.33)	29.6817
2010's	4 (16.67)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Kocsis, B; Szabo, D	1
Decramer, M; Simoens, S	1
Anzueto, A; Miravitlles, M	1
Anzueto, A; Ewig, S; Legnani, D; Miravitlles, M; Stauch, K	1
Arvis, P; Choudhri, SH; Haverstock, D; Kruesmann, F; Miravitlles, M; Perroncel, R	1
Anzueto, A; Ewig, S; Heldner, S; Legnani, D; Miravitlles, M; Stauch, K	1
Chuchalin, A; Dokic, D; Marschall, HP; Petri, T; Tokić, M; Zakharova, M	1
Casali, L; Curti, E; Grassi, C; Lazzaro, C; Schito, G; Tellarini, M	1
Iakovlev, VP; Polushkina, NR	1
Miravitlles, M; Torres, A	1
Allegra, L; Huchon, G; Izquierdo, JL; Jones, P; Sagnier, PP; Schaberg, T; Wilson, R	1
Bassaris, H; Gogos, CA; Starakis, I	1
Keating, GM; Scott, LJ	1
Cots, JM; Llor, C; Miravitlles, M; Molina, J; Naberan, K	2
Busch, W; Lorenz, J; Thate-Waschke, IM	1
Amábile-Cuevas, CF; Ariza, H; Caballero, A; García-Calderón, A; Hernández-Oliva, G; Jardim, JR; Urueta-Robledo, J; Vivar-Orozco, R	1
Dolcet, F; Furlanut, M; Lugatti, E; Pavan, F; Pea, F; Screm, MC; Talmassons, G	1
Anzueto, A; Choudhri, S; Haverstock, D; Kureishi, A; Niederman, MS; Perroncel, R; Sethi, S	1
Amsden, GW; Martinez, FJ; Rothermel, CD; Treadway, G; Zervos, M	1
Llor, C; Miravitlles, M	1
Marchese, A; Roveta, S; Schito, AM; Schito, GC	1
Miravitlles, M	1

Reviews

7 review(s) available for moxifloxacin and Chronic Bronchitis

Article	Year
A pharmacoeconomic review of the management of respiratory tract infections with moxifloxacin. Expert opinion on pharmacotherapy, 2008, Volume: 9, Issue:10 Topics: Anti-Infective Agents; Aza Compounds; Bronchitis, Chronic; Community-Acquired Infections; Costs and Cost Analysis; Fluoroquinolones; Humans; Moxifloxacin; Pneumonia, Bacterial; Quinolines; Respiratory Tract Infections; Sinusitis	2008
Moxifloxacin: a respiratory fluoroquinolone. Expert opinion on pharmacotherapy, 2008, Volume: 9, Issue:10 Topics: Anti-Bacterial Agents; Aza Compounds; Bronchitis, Chronic; Clinical Trials as Topic; Community-Acquired Infections; Fluoroquinolones; Humans; Moxifloxacin; Pneumonia, Bacterial; Quinolines; Respiratory Tract Infections; Sinusitis	2008
Sputum colour and bacteria in chronic bronchitis exacerbations: a pooled analysis. The European respiratory journal, 2012, Volume: 39, Issue:6 Topics: Anti-Bacterial Agents; Aza Compounds; Bacteria; Bronchitis, Chronic; Color; Disease Progression; Dyspnea; Female; Fluoroquinolones; Gentian Violet; Humans; Male; Moxifloxacin; Multicenter Studies as Topic; Phenazines; Pneumonia, Bacterial; Quinolines; Randomized Controlled Trials as Topic; Sex Factors; Sputum	2012
[Moxifloxacin: results of clinical use]. Antibiotiki i khimioterapiia = Antibiotics and chemoterapy [sic], 2002, Volume: 47, Issue:10 Topics: Anti-Infective Agents; Aza Compounds; Bronchitis, Chronic; Clinical Trials as Topic; Fluoroquinolones; Humans; Moxifloxacin; Pneumonia; Quinolines; Respiratory Tract Infections; Sinusitis; Skin Diseases, Bacterial; Treatment Outcome	2002
Moxifloxacin: a review of its use in the management of bacterial infections. Drugs, 2004, Volume: 64, Issue:20 Topics: Anti-Bacterial Agents; Area Under Curve; Aza Compounds; Biological Availability; Bronchitis, Chronic; Clinical Trials as Topic; Community-Acquired Infections; Fluoroquinolones; Half-Life; Humans; Intestinal Absorption; Microbial Sensitivity Tests; Moxifloxacin; Pneumonia; Quinolines; Sinusitis; Tissue Distribution; Topoisomerase II Inhibitors	2004
Eradication of H. influenzae in AECB: A pooled analysis of moxifloxacin phase III trials compared with macrolide agents. Respiratory medicine, 2006, Volume: 100, Issue:10 Topics: Acute Disease; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Aza Compounds; Azithromycin; Bronchitis, Chronic; Chronic Disease; Clarithromycin; Clinical Trials, Phase III as Topic; Double-Blind Method; Female; Fluoroquinolones; Haemophilus Infections; Haemophilus influenzae; Humans; Male; Middle Aged; Moxifloxacin; Multicenter Studies as Topic; Quinolines; Randomized Controlled Trials as Topic; Treatment Outcome	2006
Moxifloxacin in the management of exacerbations of chronic bronchitis and COPD. International journal of chronic obstructive pulmonary disease, 2007, Volume: 2, Issue:3 Topics: Adult; Anti-Infective Agents; Aza Compounds; Bronchitis, Chronic; Female; Fluoroquinolones; Humans; Male; Moxifloxacin; Pulmonary Disease, Chronic Obstructive; Quinolines; Spain; Treatment Outcome	2007

Trials

10 trial(s) available for moxifloxacin and Chronic Bronchitis

Article	Year
Characterisation of exacerbations of chronic bronchitis and COPD in Europe: the GIANT study. Therapeutic advances in respiratory disease, 2009, Volume: 3, Issue:6 Topics: Activities of Daily Living; Adult; Aged; Anti-Infective Agents; Aza Compounds; Bronchitis, Chronic; Europe; Female; Fluoroquinolones; Humans; Male; Middle Aged; Moxifloxacin; Practice Guidelines as Topic; Practice Patterns, Physicians'; Pulmonary Disease, Chronic Obstructive; Quinolines; Smoking; Spirometry; Surveys and Questionnaires	2009
Identifying patients at risk of late recovery (≥ 8 days) from acute exacerbation of chronic bronchitis and COPD. Respiratory medicine, 2012, Volume: 106, Issue:9 Topics: Acute Disease; Adult; Aged; Anti-Infective Agents; Aza Compounds; Bronchitis, Chronic; Female; Fluoroquinolones; Forced Expiratory Volume; Humans; Male; Middle Aged; Moxifloxacin; Prospective Studies; Pulmonary Disease, Chronic Obstructive; Quinolines; Recovery of Function; Risk Factors; Treatment Outcome	2012
Efficacy and safety of moxifloxacin in acute exacerbations of chronic bronchitis: a prospective, multicenter, observational study (AVANTI). BMC pulmonary medicine, 2013, Jan-23, Volume: 13 Topics: Activities of Daily Living; Acute Disease; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Aza Compounds; Bronchitis, Chronic; Female; Fluoroquinolones; Humans; Male; Middle Aged; Moxifloxacin; Prevalence; Prospective Studies; Pulmonary Disease, Chronic Obstructive; Quinolines; Risk Factors; Sleep Wake Disorders	2013
Efficacy and safety of short course (5-day) moxifloxacin vs 7-day ceftriaxone in the treatment of acute exacerbations of chronic bronchitis (AECB). Journal of chemotherapy (Florence, Italy), 2002, Volume: 14, Issue:6 Topics: Acute Disease; Aged; Anti-Infective Agents; Aza Compounds; Bronchitis, Chronic; Ceftriaxone; Costs and Cost Analysis; Female; Fluoroquinolones; Humans; Italy; Male; Middle Aged; Moxifloxacin; National Health Programs; Quinolines; Time Factors; Treatment Outcome	2002
Short-term and long-term outcomes of moxifloxacin compared to standard antibiotic treatment in acute exacerbations of chronic bronchitis. Chest, 2004, Volume: 125, Issue:3 Topics: Acute Disease; Aged; Amoxicillin; Anti-Bacterial Agents; Aza Compounds; Bronchitis, Chronic; Cefuroxime; Clarithromycin; Double-Blind Method; Female; Fluoroquinolones; Humans; Male; Middle Aged; Moxifloxacin; Quinolines	2004
Five-day moxifloxacin therapy compared with 7-day co-amoxiclav therapy for the treatment of acute exacerbation of chronic bronchitis. International journal of antimicrobial agents, 2004, Volume: 23, Issue:2 Topics: Adult; Aged; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Aza Compounds; Bacteria; Bacterial Infections; Bronchitis, Chronic; Drug Therapy, Combination; Female; Fluoroquinolones; Humans; Male; Middle Aged; Moxifloxacin; Quinolines; Sputum; Treatment Outcome	2004
[Moxifloxacin in the treatment of chronic bronchitis--clinical evaluation and assessment by patients]. Fortschritte der Medizin. Originalien, 2000, Jul-27, Volume: 118 Suppl 2 Topics: Adult; Aged; Aged, 80 and over; Aza Compounds; Bronchitis, Chronic; Cough; Female; Fluoroquinolones; Forced Expiratory Volume; Humans; Male; Middle Aged; Moxifloxacin; Patient Satisfaction; Quality of Life; Quinolines; Risk Factors; Smoking; Surveys and Questionnaires; Time Factors; Treatment Outcome	2000
Variables associated with recovery from acute exacerbations of chronic bronchitis and chronic obstructive pulmonary disease. Respiratory medicine, 2005, Volume: 99, Issue:8 Topics: Acute Disease; Adrenergic beta-Agonists; Adult; Aged; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Aza Compounds; Bronchitis, Chronic; Clarithromycin; Drug Therapy, Combination; Epidemiologic Methods; Female; Fluoroquinolones; Humans; Male; Middle Aged; Moxifloxacin; Oxygen Inhalation Therapy; Prognosis; Pulmonary Disease, Chronic Obstructive; Quinolines; Treatment Outcome	2005
Moxifloxacin versus levofloxacin against acute exacerbations of chronic bronchitis: the Latin American Cohort. Respiratory medicine, 2006, Volume: 100, Issue:9 Topics: Anti-Bacterial Agents; Anti-Infective Agents; Argentina; Aza Compounds; Brazil; Bronchitis, Chronic; Colombia; Double-Blind Method; Female; Fluoroquinolones; Humans; Levofloxacin; Male; Mexico; Middle Aged; Moxifloxacin; Ofloxacin; Peru; Prospective Studies; Quinolines; Treatment Outcome	2006
Efficacy and safety of 3-day azithromycin versus 5-day moxifloxacin for the treatment of acute bacterial exacerbations of chronic bronchitis. International journal of antimicrobial agents, 2007, Volume: 29, Issue:1 Topics: Abdominal Pain; Adult; Aged; Anti-Bacterial Agents; Aza Compounds; Azithromycin; Bronchitis, Chronic; Drug Administration Schedule; Female; Fluoroquinolones; Haemophilus influenzae; Haemophilus parainfluenzae; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Moraxella catarrhalis; Moxifloxacin; Nausea; Patient Compliance; Quinolines; Single-Blind Method; Streptococcus pneumoniae; Treatment Outcome; Vaginitis	2007

Other Studies

7 other study(ies) available for moxifloxacin and Chronic Bronchitis

Article	Year
Zabofloxacin for chronic bronchitis. Drugs of today (Barcelona, Spain : 1998), 2016, Volume: 52, Issue:9 Topics: Anti-Infective Agents; Bronchitis, Chronic; Clinical Studies as Topic; Drug Administration Routes; Drug Evaluation, Preclinical; Fluoroquinolones; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Moxifloxacin; Respiratory Tract Infections; Treatment Outcome	2016
[Acute exacerbated chronic bronchitis. Antibiotics in comparison]. MMW Fortschritte der Medizin, 2003, Oct-02, Volume: 145, Issue:40 Topics: Acute Disease; Amoxicillin; Anti-Bacterial Agents; Aza Compounds; Bronchitis, Chronic; Cefuroxime; Clarithromycin; Fluoroquinolones; Humans; Moxifloxacin; Quinolines; Randomized Controlled Trials as Topic; Smoking; Time Factors	2003
No more equivalence trials for antibiotics in exacerbations of COPD, please. Chest, 2004, Volume: 125, Issue:3 Topics: Acute Disease; Anti-Bacterial Agents; Aza Compounds; Bronchitis, Chronic; Clinical Trials as Topic; Fluoroquinolones; Humans; Moxifloxacin; Pulmonary Disease, Chronic Obstructive; Quinolines	2004
Economic evaluation of the antibiotic treatment of exacerbations of chronic bronchitis and COPD in primary care. International journal of clinical practice, 2004, Volume: 58, Issue:10 Topics: Aged; Amoxicillin; Anti-Bacterial Agents; Aza Compounds; Bronchitis, Chronic; Clarithromycin; Clavulanic Acid; Cost of Illness; Cost-Benefit Analysis; Data Collection; Female; Fluoroquinolones; Humans; Male; Moxifloxacin; Pilot Projects; Pulmonary Disease, Chronic Obstructive; Quinolines; Treatment Outcome	2004
Pharmacokinetic and pharmacodynamic aspects of oral moxifloxacin 400 mg/day in elderly patients with acute exacerbation of chronic bronchitis. Clinical pharmacokinetics, 2006, Volume: 45, Issue:3 Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Area Under Curve; Aza Compounds; Bronchitis, Chronic; Chromatography, High Pressure Liquid; Cohort Studies; Female; Fluoroquinolones; Humans; Male; Moxifloxacin; Quinolines	2006
Determining factors in the prescription of moxifloxacin in exacerbations of chronic bronchitis in the primary-care setting. Clinical drug investigation, 2007, Volume: 27, Issue:2 Topics: Adrenal Cortex Hormones; Aged; Anti-Bacterial Agents; Aza Compounds; Bronchitis, Chronic; Drug Utilization; Female; Fluoroquinolones; Humans; Male; Middle Aged; Moxifloxacin; Practice Patterns, Physicians'; Primary Health Care; Quinolines; Severity of Illness Index	2007
Activity of moxifloxacin on biofilms produced in vitro by bacterial pathogens involved in acute exacerbations of chronic bronchitis. International journal of antimicrobial agents, 2007, Volume: 30, Issue:5 Topics: Anti-Bacterial Agents; Aza Compounds; Biofilms; Biomass; Bronchitis, Chronic; Fluoroquinolones; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Microbial Sensitivity Tests; Moxifloxacin; Quinolines; Spectrophotometry	2007